Tom Burt

Tom Burt is an Investment Advisory Professional specializing in the healthcare sector at Triton Partners. He joined the private equity firm in 2023 after previously serving as a Partner at Sofinnova Partners, where he directed venture capital investments across the broader life sciences industry. Before transitioning into institutional investing, Burt gained direct pharmaceutical industry experience by starting his professional career as a Research Engineer at GlaxoSmithKline. His technical expertise is supported by an extensive academic background, including an Engineering Doctorate in Biochemical Engineering and Bioprocess Leadership from University College London. He also holds a Master of Science in Biochemical Engineering from the University of Birmingham and a biotechnology degree from the University of Leeds. Burt currently leverages his engineering background to evaluate and execute late-stage private equity investments throughout the European healthcare, bioprocess, and biotechnology markets.